Background. Polymerase chain reaction (PCR) is becoming more common in diagnostic laboratories. In some instances, its value has been established. In other cases, assays exist, but their beneficial use has not been determined. This article summarizes findings from 3485 patients who underwent testing over a 6-year period in our laboratory.
During the previous decade, nucleic acid amplification technology, particularly PCR, has had increasingly broader application and acceptance in the clinical laboratory. These methods have proven to be especially useful in situations in which the agent of interest either cannot be recovered in vitro or normal recovery times are too long to be useful in treating or caring for the patient. One of the more challenging of such problems has been the diagnosis of viral infections of the CNS. In this regard, PCR has been shown to be suitable for the detection of CNS infections due to herpes simplex virus (HSV), for which it has become accepted as the new standard [1] [2] [3] . Likewise, with the addition of a reverse transcription step to convert RNA to cDNA, RT-PCR is at least as sensitive as cell culture for detecting CNS infections associated with enteroviruses, and it is more rapid than virus recovery in cell culture [4] .
Primer pairs have been identified and reported for amplification of most viruses of either clinical or experimental interest. In contrast, there have been comparatively few reports of the application of PCR to relatively large numbers of patients with suspected viral CNS infections [5] [6] [7] [8] [9] . For several years, the Virology Laboratories at the New York State Department of Health's Wadsworth Center (Albany) have been using a battery of PCR assays designed for application to CSF Downloaded from https://academic.oup.com/cid/article-abstract/39/5/630/361928 by guest on 04 February 2019 and brain tissue to detect a range of viruses. The viruses that can be detected in the battery of PCR tests include arboviruses of interest in New York that are associated with infections of the CNS. The outcomes for the first 106 patients were previously reported [10] . This article summarizes the results obtained for 3485 patients with apparent CNS infection during 1997-2003 and for 280 patients for whom medical chart reviews were conducted. In addition to the PCR/RT-PCR findings, important observations emerged concerning the clinical criteria used to distinguish between encephalitis and meningitis and the proportion of such cases for which an etiology was never determined.
PATIENTS, METHODS, AND MATERIALS
Patients and data. The study group comprised patients who received a diagnosis of encephalitis or meningitis of unknown etiology and had CSF and/or brain tissue samples submitted to the Clinical Virology Laboratory at the New York State Department of Health (NYSDOH; Albany) between 1 July 1997 and 30 September 2003. Health care professionals or hospitals throughout New York State submitted the samples for testing with no selection or limitation by the Clinical Virology Laboratory except that a sample of sufficient quantity (0.5 mL for CSF and 0.05 g for tissue) be available to permit adequate testing. In addition, our study included a few patients who had specimens accepted upon request from physicians in other parts of the United States. Patient data were obtained from a specially designed form that accompanied submitted specimens. It included basic demographic characteristics (age, sex, and place of residence) and clinical data (symptoms, time of onset, CSF cell counts, and glucose and protein levels). In addition, detailed patient data were collected on the subset of patients hospitalized during [1997] [1998] [1999] [12] [13] [14] [15] [16] [17] [18] are listed in table 1. The thermal profile for PCR consisted of an initial 15 min at 95ЊC, followed by 45 repetitive cycles of 60 s at 95ЊC, of 60 s at 52ЊC (for RNA viruses) or 60ЊC (for DNA viruses), and of 60 s at 72ЊC, followed by a 10-min extension at 72ЊC for 1 cycle. Amplification products were analyzed on a 2% agarose gel (EM Science) containing ethidium bromide. For any virus for which a band corresponding to a positive test result was observed, the band was excised from the low-melting agarose gel and was sequenced directly on the gel slice without further purification. Dye-terminator sequencing was performed using an automated sequencer (model 373A; Applied Biosystems).
RESULTS
Clinical specimens of CSF or tissue were simultaneously examined for a panel of 11 viruses by PCR and/or RT-PCR, as described in Patients, Methods, and Materials. A summary of the test results with respect to patient age and virus is presented in table 2. Of the 3465 patients for whom data on sex were available, 1829 (52.8%) were male and 1636 (47.2%) were female. A total of 498 (14.3%) of 3465 patients were PCR-positive for 1 of the viruses tested for in the panel. Of these 498 patients, 273 (54.9%) were male and 225 (45.1%) were female. Enteroviruses accounted for the largest fraction of the positive PCR results, followed by HSV, VZV, and WNV. There were 6 patients, all of whom were immunocompromised, with CSF samples that tested positive for CMV. EBV was also found in the CSF of 4 patients. Three of these were EBV type 2 and were from immunocompromised individuals. The fourth was EBV type 1, but the accompanying data were insufficient to allow a con- clusion to be drawn about the patient's immunologic status. There were also 4 patients who tested positive for arboviruses of the California serogroup; 2 were LAC viruses, and 2 were Jamestown Canyon viruses. The latter cases of Jamestown Canyon virus infections were particularly noteworthy and have been reported elsewhere [19] . On the basis of travel history data, it appears that a single patient who tested positive for SLE had become infected elsewhere and became ill shortly after returning to New York.
The viruses most frequently detected, enteroviruses and HSV, were found across a broad age spectrum. The numbers for the other viruses were too small to generalize, although the age characteristics associated with the cases of WNV reflected the well-known tendency of WNV to produce the most-serious infections in patients 150 years of age [20] .
The NYSDOH was also a participant in a wider Centers for Disease Control and Prevention-sponsored program addressing encephalitis, in which this syndrome was defined as including the following criteria: age of 16 months, an altered mental state persisting for 124 h, and у1 of the following symptoms: fever, seizures, focal neurological findings, abnormal CSF findings, and abnormal electroencephalographic or neuroimaging findings. To identify cases for analysis, these criteria were applied to the case histories that accompanied the specimens. The results are shown in table 3. The first row in the table recapitulates the overall PCR findings in terms of positive results by virus.
The second row shows similar data for patients meeting the above definition of encephalitis. It is not too surprising that the greatest number of positive PCR results excluded according to the criteria were associated with enteroviral infections, although the exclusions were not limited exclusively to that group of viruses. The third and fourth rows in the table illustrate the effect on the study results of omitting either altered mental status or age 16 months from the selection criteria. The effect of the former can be seen to be especially significant. The information in the fifth row demonstrates that the use of these 2 variables alone (rate of positive results, 7.4%) is sufficient to obtain essentially the same outcome as that obtained when the complete definition was employed (rate of positive results, 7.8%).
It has been reported that elevated leukocyte counts and/or elevated protein levels are useful in screening CSF specimens to identify those situations in which the benefits of PCR are more likely to be realized [7] . Tang et al. [7] defined elevated protein levels as 145 mg/dL and elevated leukocyte counts as 15 nucleated cells/mm 3 . Among the 3485 patients who underwent testing by our laboratory, suitable information for a similar evaluation was available for 2954. Of the latter group, 2492 (84.4%) met one or both of the above criteria. Of the 449 PCRpositive patients with relevant data, 431 (96%) met one or both criteria. Of the 18 positive results in patients without elevated values, 15 were for enteroviruses, 2 were for WNV, and 1 was for CMV. One of the most important questions with regard to the successful use of any assay to detect virus in a particular specimen is the best time, during the course of illness, at which to obtain the specimen. With a specimen such as CSF, it is not possible to do a time-course evaluation, and the necessary data can only be compiled empirically. This information is presented in table 4 for the PCR-positive specimens tested in our laboratory. It should be noted that this compilation is based on the number of specimens and also that the date of onset of symptoms must have been provided by the submitter. Consequently, for some viruses, the numbers are less than the number of patients with PCR-positive results, whereas for others (because 11 CSF specimen was received for some patients), the numbers are greater than the number of patients with PCR-positive results. It can be seen that the highest detection rate (18.3%) occurs with specimens collected within the first 2 days after onset. Between days 3 and 5, the rate decreases to 15.6%. It decreases thereafter, so that by 10-14 days and beyond, it is !10%. Overall, the positive rate for specimens collected within 5 days after illness onset was 17.2% (365 of 2112 patients), compared with 8.6% (121 of 1402 patients) for specimens collected у6 days after onset (risk ratio, 2.0; 95% CI, 1.65-2.43). When enteroviruses were omitted from this evaluation, there was much less variation in the proportion of specimens yielding positive results: roughly 4%-6% of specimens collected during period included in the analysis tested positive for virus.
To obtain a more thorough overview of the course of illness and how it was finally resolved, medical charts were requested for 399 patients tested during 1997-1999. For the 280 charts received and reviewed, the median age range was 31-40 years. Male subjects comprised 52% of the patients, and female subjects comprised 48%, which was very similar to the sex ratio for the total population tested. Table 5 summarizes other findings from the chart review as they relate to the final resolution of the cases. A total of 69 cases (24.6%) were resolved by PCR testing. Chart review revealed that an apparent diagnosis was made for an additional 71 patients (25.4%). Therefore, ∼50% of the cases with a suspected infectious etiology remained unresolved. 
DISCUSSION
Sufficient data have been accumulated to conclusively demonstrate the value of PCR in the diagnosis of viral infection. The topics of greater concern now are the situations and circumstances in which PCR is best deployed. In the case of HSV and enteroviruses, PCR can be considered the new standard for diagnosis, because there are sufficient data from various laboratories supporting its use for diagnosis of CNS infections due to these viruses. Although the available information for other viruses is promising, appropriate bases for comparison are often limited, and it is more difficult to form a definite opinion. For example, with respect to WNV, it has been reported that PCR has a sensitivity of ∼60%, compared with serologically confirmed cases in the outbreak in New York in 1999 [21] . Our experience is in accord with this finding. However, the difficulty in recovering WNV from human patients by cell culture has resulted in PCR assays and nucleic acid sequence analysis providing almost all of the current knowledge on the relationships among the variant associated with human infections in North America, the variant circulating in animals, and isolates from other parts of the world. Thus, even with decreased sensitivity for diagnostic purposes, the value of employing PCR for diagnosing cases of WNV infection is undeniable. With regard to other arboviruses, particularly those of the California serogroup, PCR appears to have a greater sensitivity (∼90% or higher) than it does for WNV (NYSDOH, unpub-lished data). Furthermore, PCR has provided valuable information on the molecular characteristics of the Jamestown Canyon variant associated with human infections [19] . To our knowledge, to date, this is the only information available, because as yet there have been no human isolates of Jamestown Canyon virus.
The chart review results imply that only ∼50% of apparent CNS infections are ultimately resolved. This information is not readily available to the laboratory at the time of specimen submission and can only be obtained by follow-up. It is interesting to note that the 50% estimate for the proportion of all CNS infections that are unresolved is not too different from the recently published value of 62% for encephalitis cases similarly categorized [22] . The importance of this observation is at least 2-fold. First, the final resolution of the case must be known in any attempt to estimate the number of cases of suspected CNS infection that are undiagnosed. Second, it is relevant to attempts to understand why the proportion of cases that were PCRpositive has decreased over time. Our initial findings were that 37% of the patients from whom specimens were received were PCR positive [10] , whereas after 6 years, the proportion has decreased to 14.3%. We suggest the following 2 likely explanations: there has been a substantial increase during the past few years in the number of private laboratories that offer diagnostic PCR for HSV and enteroviruses (the 2 viruses that account for the largest number of positive PCR results), and the WNV infection outbreak in New York in 1999 may have resulted in specimens being submitted that were associated with a broader range of clinical symptoms than had previously been the case. Additional chart reviews will eventually clarify the contributions of these possibilities.
